tiprankstipranks

Mark Glickman Insider Profile

4 Followers
Mark Glickman, CCO at Aralez Pharmaceuticals, holds 9.74K shares in MetaVia (Ticker: MTVA), holds 1.29K shares in TherapeuticsMD (Ticker: TXMD), holds 250.19K shares in Aralez Pharmaceuticals (Ticker: ARLZQ).
tipranks
Mark Glickman

Mark Glickman
Aralez Pharmaceuticals (ARLZQ)
CCO

Not Ranked
Mark Glickman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$17K
91.56%
8.44%
A breakdown of Mark Glickman's holdings

Insider Roles

MetaVia
(MTVA)
Director
TherapeuticsMD
(TXMD)
Co- CEO
Roles that Mark Glickman holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Mark Glickman

Mark Glickman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARLZQ
Aralez Pharmaceuticals
Mar 21, 2018
Uninformative Sell
9.73K
$500.38
TherapeuticsMD
Dec 09, 2022
Co- CEO
Uninformative Buy
6.37K
$1.44K
MetaVia
Jun 07, 2024
Director
Uninformative Buy
$15.58K
AUXL
Auxilium
Jan 30, 2015
Uninformative Sell
1.02M
List of latest transactions for each holding click on a transaction to see Mark Glickman's performance on stock

Mark Glickman insider profile FAQ

What is the percentage of profitable transactions made by Mark Glickman?
The percentage of profitable transactions made by Mark Glickman is ―.
    What is the average return per transaction made by Mark Glickman?
    The average return per transaction made by Mark Glickman is ―.
      What stocks does Mark Glickman hold?
      Mark Glickman holds: ARLZQ, TXMD, MTVA, AUXL stocks.
        What was Mark Glickman’s latest transaction?
        Mark Glickman latest transaction was an Uninformative Buy of ―.
          What was Mark Glickman's most profitable transaction?
          Mark Glickman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Mark Glickman's role in Aralez Pharmaceuticals?
            Mark Glickman's role in Aralez Pharmaceuticals is CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.